# OnCo record nct01106235 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01106235/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01106235", "NCT01106235" ;
  schema:name "IL-21-modulated CD8+ antigen-specific T cells with cyclophosphamide and aldesleukin in metastatic melanoma (Fred Hutchinson phase 1, terminated)"@en ;
  schema:description "A Seattle trial of melanoma-targeting T cells treated in the laboratory with the immune signal IL-21 before infusion. The registry lists it as terminated in 2011 and gives no reason."@en ;
  schema:url <https://onco.cc/trials/nct01106235/> ;
  schema:dateModified "2026-11-05"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01106235> ;
  onco:status "withdrawn" ;
  onco:phase "1" ;
  schema:startDate "2010-04" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/aldesleukin/> ;
  onco:institutions <https://onco.cc/institutions/fred-hutch/>, <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/endogenous-t-cell-therapy/> ;
  onco:people <https://onco.cc/people/cassian-yee/> .